| Literature DB >> 30147948 |
Kaijian Chen1, Zongli Hu1, Jihan Zhou1, Ting Yu1, Jie Xu1, Ji Bai1, Jian Ye1.
Abstract
PURPOSE: To estimate the treatment effectiveness of femtosecond-assisted laser in situ keratomileusis (FS-LASIK) and Toric implantable collamer lens (Toric ICL) for moderate and high astigmatism via vector analysis.Entities:
Year: 2018 PMID: 30147948 PMCID: PMC6083598 DOI: 10.1155/2018/6952710
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Demographic data of the FS-LASIK and Toric ICL groups.
| FS-LASIK group | Toric ICL group |
| |
|---|---|---|---|
| Patients/eyes ( | 22/22 | 22/22 | — |
| Eye, right (%) | 54.55 | 40.91 | 0.36 |
| Sex, male (%) | 50 | 31.82 | 0.38 |
| Age ( | 22.72 ± 4.85 (18 to 33) | 25.27 ± 5.49 (18 to 35) | 0.11 |
| Presphere (D) | −6.97 ± 1.20 (−9.25 to −5.00) | −8.32 ± 3.14 (−14.00 to −2.00) | 0.07 |
| Precylinder (D) | −2.40 ± 0.59 (−3.50 to −1.25) | −2.28 ± 0.88 (−4.00 to −1.00) | 0.57 |
| Pre-SE (D) | −8.18 ± 1.10 (−10.25 to −6.75) | −9.47 ± 2.99 (−15.00 to −3.75) | 0.07 |
| Preaxial | 17.50/5.00/172.50 (0 to 175) | 5.00/0.00/78.75 (0 to 175) | 0.06# |
| Pre-CDVA (logMAR) | 0.04 ± 0.06 (0 to 0.2) | 0.06 ± 0.09 (0 to 0.3) | 0.31 |
| Postsphere (D) | −0.08 ± 0.40 (−1.00 to 0.75) | 0.13 ± 0.49 (−0.5 to 2.00) | 0.14 |
| Postcylinder (D) | −0.19 ± 0.33 (−1.00 to 0.25) | −0.27 ± 0.37 (−1.25 to 0) | 0.45 |
| Post-SE (D) | −0.18 ± 0.45 (−1.25 to 0.75) | −0.01 ± 0.43 (−0.5 to 1.38) | 0.23 |
| Postaxial | 0.00/0.00/85.00 (0 to 155) | 0.00/0.00/46.25 (0 to 170) | 0.36 |
| Post-CDVA (logMAR) | 0.01 ± 0.03 (0 to 0.1) | 0.02 ± 0.04 (0 to 0.1) | 0.43# |
Pre: preoperative values; SE: spherical equivalent; normal distribution variables: mean ± SD (range); abnormal distribution variables: median/Q25/Q75 (range); chi-squared test; independent sample T-test; Mann–Whitney U test.
Figure 1Postoperative spherical equivalent in dioptres (D) between FS-LASIK and Toric ICL.
Figure 2Postoperative refractive astigmatism in dioptres (D) between FS-LASIK and Toric ICL.
Vector parameters for FS-LASIK and Toric ICL.
| FS-LASIK group ( | Toric ICL group ( |
| |
|---|---|---|---|
| IRC | 2.00 ± 0.50 (1.01 to 3.00) | 1.86 ± 0.76 (0.77 to 1.86) | 0.47 |
| SIRC | 1.95 ± 0.48 (1.01 to 3.00) | 1.76 ± 0.81 (0.77 to 3.30) | 0.36 |
| EV | 0.25/0.00/0.31 (0 to 0.97) | 0.00/0.00/0.49 (0 to 1.29) | 0.86# |
| CR | 1.00/0.91/1.00 (0.69 to 1.28) | 1.00/1.00/0.92 (0.41 to 1.21) | 0.96# |
| ER | 0.12/0.00/0.19 (0 to 0.39) | 0.00/0.00/0.30 (0 to 0.61) | 0.92# |
| EM | 0.00/0.00/0.17 (−0.47 to 0.77) | 0.00/0.00/0.22 (−0.35 to 1.24) | 0.98# |
| EA | 0.00/−2.00/0.00 (−10 to 8) | 0.00/−4.25/0.00 (−14 to 13) | 0.81# |
RC: intended refractive correction; SIRC: surgically induced refractive correction; EV: error vector; CR: correction ratio; ER: error ratio; EM: error of the magnitude; normal distribution variables: mean ± SD (range); abnormal distribution variables: median/Q25/Q75 (range); #Mann–Whitney U test; independent sample T-test.
Figure 3Astigmatism correction ratio in FS-LASIK and Toric ICL.
Figure 4Correct axis between the achieved treatment and the intended treatment in FS-LASIK.
Figure 5Correct axis between the achieved treatment and the intended treatment in Toric ICL.